Imunon, Inc. — Director's Dealing 2021

Mar 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2021-03-19

Reporting Person: Tumminello Timothy J (Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-19	Option to Purchase Celsion Corporation Common Stock	$2.24	A	65000	Acquired	2031-03-19	Celsion Corporation Common Stock (65000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The options vest as follows: 1/3 immediately; 1/3 on the first year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant.